CSPC Pharmaceutical (石药集团)

CSPC Pharmaceutical Group Limited (石药集团) is one of China's largest integrated pharmaceutical companies, established in 1997 and headquartered in Shijiazhuang, Hebei Province. The company researches, develops, manufactures, and distributes both active pharmaceutical ingredients (APIs) and finished formulations across a broad therapeutic portfolio — including penicillin, cephalosporins, penem preparations, butylphthalide (NBP, a leading cerebrovascular drug), analgesics, and approximately 1,000 other products. CSPC operates more than 10 pharmaceutical production bases globally, distributes to over 100 countries and regions, and employs more than 28,000 people across its subsidiaries. It is listed on the Hong Kong Stock Exchange (ticker: 1093) and had total assets of approximately 64 billion yuan as of its most recent reporting.